How food and age affect a new study drug
Part of Brain & nervous system, Mental health clinical trials.
This early-phase study looks at how a new investigational drug (LY03017) moves through the body when taken with or without food, and how it works in younger adults (18–45) compared to older adults (65+). Participation could help researchers find the right dose and understand how the drug is processed, which is a first step toward finding a treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old, or 65 or older.
- You must weigh at least 110 pounds (50 kg) if you're a man, or 99 pounds (45 kg) if you're a woman, and your body mass index (BMI) must be between 18.5 and 28.
- You must be willing to follow study rules about diet, smoking, alcohol, and lifestyle (such as avoiding certain foods and drinks).
- You must not have significant untreated medical conditions. If you're 65 or older, you can join if your chronic conditions (like high blood pressure or diabetes) are well controlled.
- You must not have taken most prescription or over-the-counter medications within 4 weeks of starting the study (some exceptions for stable conditions in older adults).
- You must not have allergies to the study drug or similar drugs, and you must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early study to test a new drug called LY03017 in healthy adults. It will check how safe the drug is and how your body handles it at different dose levels.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial studies a new drug called FB418 to see if it's safe and how the body handles it. It first tests single doses in younger healthy men, then multiple doses, and also includes an optional group for healthy older adults.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
Hear when a new Alzheimer's Disease Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.